James Graham: CEO of Recce Pharmaceuticals

Portrait of James Graham

James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs.

Gemini Therapeutics employee in lab.
Gemini Therapeutics

We See Disease Differently

Silicon Therapeutics employee at microscope
Silicon Therapeutics

A Quantum Leap in Medicine

Overseas Shipholding Group

Moving Energy with Integrity